Skip to content

Curr Top Behav Neurosci

ISSN 1866-3370; 1866-3389;

6 papers in the library · 437 citations · publishing 2018-2024

Papers

Sort Most recent Most cited

Psychedelic Harm Reduction and Integration: A Transtheoretical Model for Clinical Practice.

Curr Top Behav Neurosci December 10, 2024 Xiaojue Hu, Ingmar Gorman, Elizabeth M. Nielson 3 citations

Psychedelic Harm Reduction and Integration (PHRI) is a transtheoretical clinical model for working with psychedelic experiences in therapeutic settings. Drawing from harm reduction psychotherapy, psychedelic-assisted therapy, mindfulness-based modalities, and psychodynamic therapy, PHRI offers a framework for clinicians to assist clients in preparing for and integrating psychedelic experiences...

Epistemic Risk Reduction in Psychedelic-Assisted Therapy.

Curr Top Behav Neurosci November 2, 2024 Chiara Caporuscio, Sascha Benjamin Fink 7 citations

Belief change is crucial to therapeutic benefit in psychedelic-assisted therapy as well as in more traditional forms of therapy. However, the use of psychedelics comes with a few unique challenges that require extra caution. First, drastic belief changes may occur faster than in regular therapy. Facing radical and transformative insights all at once rather than through a gradual process of...

Classic Hallucinogens and Mystical Experiences: Phenomenology and Neural Correlates.

Curr Top Behav Neurosci 2018 Frederick S. Barrett, Roland R. Griffiths 268 citations

This chapter begins with a brief review of descriptions and definitions of mystical-type experiences and the historical connection between classic hallucinogens and mystical experiences. The chapter then explores the empirical literature on experiences with classic hallucinogens in which claims about mystical or religious experiences have been made. A psychometrically validated questionnaire is...

Therapeutic Applications of Classic Hallucinogens.

Curr Top Behav Neurosci 2018 Michael P. Bogenschutz, Stephen Ross 84 citations

This chapter reviews what is known about the therapeutic uses of the serotonergic or classic hallucinogens, i.e., psychoactive drugs such as LSD and psilocybin that exert their effects primarily through agonist activity at serotonin 2A (5HT2A) receptors. Following a review of the history of human use and scientific study of these drugs, the data from clinical research are summarized, including...

New World Tryptamine Hallucinogens and the Neuroscience of Ayahuasca.

Curr Top Behav Neurosci 2018 Dennis J. Mckenna, Jordi Riba 67 citations

New World indigenous peoples are noted for their sophisticated use of psychedelic plants in shamanic and ethnomedical practices. The use of psychedelic plant preparations among New World tribes is far more prevalent than in the Old World. Yet, although these preparations are botanically diverse, almost all are chemically similar in that their active principles are tryptamine derivatives, either...